Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1980-4-23
|
pubmed:abstractText |
Administration of 24 mumol/kg of bretylium 10 h after ganglionectomy delayed the loss of endogenous norepinephrine and the impairment of neuronal uptake of 3H-metaraminol (3H-MA) that follow sympathetic denervation. This delay was evident 16 and 20 h after denervation. Twenty four h after ganglionectomy, when NE stores and uptake of 3H-MA were reduced to their lowest values in untreated rats, in bretylium-treated ones these values were approximately 40% of those in normal glands. The onset of degeneration secretion in treated rats was delayed by about 9 h. The development of prejunctional supersensitivity was also delayed. The subcellular distribution of NE in normal and 16 h denervated glands showed that denervation reduced the neurotransmitter to the same extent in the 3 fractions: coarse, supernatant and microsomal. Treatment with bretylium and pargyline prevented the loss of NE from the microsomal fraction. Previous administration of pargyline antagonized the protection of 3H-MA uptake seen in 28 h denervated rats treated with bretylium. However, this drug combination induced a greater retention of endogenous NE 24 h after denervation. Bretylium inhibited intraneuronal MAO by 40%. It is concluded that bretylium treatment can delay the degeneration of adrenergic nerve terminals separated from the cell bodies by a pharmacological effect probably not related to MAO inhibition or to its neurone blocking action.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bretylium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Metaraminol,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Pargyline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147-57
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7353586-Animals,
pubmed-meshheading:7353586-Bretylium Compounds,
pubmed-meshheading:7353586-Dose-Response Relationship, Drug,
pubmed-meshheading:7353586-Drug Interactions,
pubmed-meshheading:7353586-Female,
pubmed-meshheading:7353586-Metaraminol,
pubmed-meshheading:7353586-Monoamine Oxidase,
pubmed-meshheading:7353586-Nerve Degeneration,
pubmed-meshheading:7353586-Nerve Endings,
pubmed-meshheading:7353586-Norepinephrine,
pubmed-meshheading:7353586-Pargyline,
pubmed-meshheading:7353586-Rats,
pubmed-meshheading:7353586-Saliva,
pubmed-meshheading:7353586-Submandibular Gland,
pubmed-meshheading:7353586-Sympathectomy,
pubmed-meshheading:7353586-Sympathetic Nervous System,
pubmed-meshheading:7353586-Time Factors
|
pubmed:year |
1980
|
pubmed:articleTitle |
Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
|
pubmed:publicationType |
Journal Article
|